{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:26:59Z","timestamp":1794882419722,"version":"4.9.1"},"reference-count":148,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Bladder cancer (BC) is a malignant tumor characterized by a high incidence of urinary system diseases. The complex pathogenesis of BC has long been a focal point in medical research. With the robust development of epigenetics, the crucial role of epigenetic modifications in the occurrence and progression of BC has been elucidated. These modifications not only affect gene expression but also impact critical biological behaviors of tumor cells, including proliferation, differentiation, apoptosis, invasion, and metastasis. Notably, DNA methylation, an important epigenetic regulatory mechanism, often manifests as global hypomethylation or hypermethylation of specific gene promoter regions in BC. Alterations in this methylation pattern can lead to increased genomic instability, which profoundly influences the expression of proto-oncogenes and tumor suppressor genes. MiRNAs, as noncoding small RNAs, participate in various biological processes of BC by regulating target genes. Consequently, this work aims to explore the interaction mechanisms between DNA methylation and miRNAs in the occurrence and development of BC. Research has demonstrated that DNA methylation not only directly influences the expression of miRNA genes but also indirectly affects the maturation and functionality of miRNAs by modulating the methylation status of miRNA promoter regions. Simultaneously, miRNAs can regulate DNA methylation levels by targeting key enzymes such as DNA methyltransferases (DNMTs), thereby establishing a complex feedback regulatory network. A deeper understanding of the crosstalk mechanisms between DNA methylation and miRNAs in BC will contribute to elucidating the complexity and dynamics of epigenetic modifications in this disease, and may provide new molecular targets and strategies for the early diagnosis, treatment, and prognostic evaluation of BC.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1518144","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:38:40Z","timestamp":1738741120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs"],"prefix":"10.3389","volume":"16","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41598-018-19199-z","article-title":"The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection","volume":"8","author":"Wong","year":"2018","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: A global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.01.032","article-title":"Quality of life after bladder cancer: A cross-sectional survey of patient-reported outcomes","volume":"79","author":"Catto","year":"2021","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of bladder cancer: A systematic review and contemporary update of risk factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/ju.0000000000000593","article-title":"Use and validation of the AUA\/SUO risk grouping for nonmuscle invasive bladder cancer in a contemporary cohort","volume":"203","author":"Ritch","year":"2020","journal-title":"J Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer","volume":"71","author":"Alfred Witjes","year":"2017","journal-title":"Eur Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: A review","volume":"324","author":"Lenis","year":"2020","journal-title":"Jama"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59122063","article-title":"Is systemic immune-inflammation index a real non-invasive biomarker to predict oncological outcomes in patients eligible for radical cystectomy","volume":"59","author":"Russo","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/551S34a","article-title":"Unlocking bladder cancer","volume":"551","author":"Berdik","year":"2017","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/218525a0","article-title":"Towards a theoretical biology","volume":"218","author":"Waddington","year":"1968","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.293.5532.1103","article-title":"Genes, genetics, and epigenetics: a correspondence","volume":"293","author":"Wu","year":"2001","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-024-02088-7","article-title":"Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance","volume":"23","author":"Wang","year":"2024","journal-title":"Mol Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13148-020-00896-4","article-title":"The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus","volume":"12","author":"Ahmed","year":"2020","journal-title":"Clin Epigenetics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2020.100044","article-title":"Involvement of long noncoding RNAs in the pathogenesis of autoimmune diseases","volume":"3","author":"Zou","year":"2020","journal-title":"J Transl Autoimmun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41392-024-01938-6","article-title":"Circulating tumor cells: from new biological insights to clinical practice","volume":"9","author":"Gu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-023-04512-y","article-title":"Hypermethylated ITGA8 facilitate bladder cancer cell proliferation and metastasis","volume":"196","author":"Ma","year":"2024","journal-title":"Appl Biochem Biotechnol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205304","article-title":"DOK7, a target of miR-299-5p, suppresses the progression of bladder cancer","volume":"15","author":"Tian","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000495273","article-title":"miR-1-3p contributes to cell proliferation and invasion by targeting glutaminase in bladder cancer cells","volume":"51","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26591","article-title":"MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B","volume":"234","author":"Zo","year":"2018","journal-title":"J Cell Physiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12751","article-title":"CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer","volume":"53","author":"Ying","year":"2020","journal-title":"Cell Prolif"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03240-z","article-title":"Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p\/Smad3 axis","volume":"11","author":"Kang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature11233","article-title":"Landscape of transcription in human cells","volume":"489","author":"Djebali","year":"2012","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1138341","article-title":"RNA maps reveal new RNA classes and a possible function for pervasive transcription","volume":"316","author":"Kapranov","year":"2007","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12986-018-0305-8","article-title":"MicroRNAs from plants to animals, do they define a new messenger for communication","volume":"15","author":"Li","year":"2018","journal-title":"Nutr Metab (Lond)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600385","article-title":"MicroRNA genes are transcribed by RNA polymerase II","volume":"23","author":"Lee","year":"2004","journal-title":"EMBO J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdf476","article-title":"MicroRNA maturation: stepwise processing and subcellular localization","volume":"21","author":"Lee","year":"2002","journal-title":"EMBO J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030235","article-title":"Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells","volume":"3","author":"Saito","year":"2005","journal-title":"PLoS Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1064023","article-title":"Argonaute2, a link between genetic and biochemical analyses of RNAi","volume":"293","author":"Hammond","year":"2001","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.01.044","article-title":"MicroRNA in prostate, bladder, and kidney cancer: a systematic review","volume":"59","author":"Catto","year":"2011","journal-title":"Eur Urol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.174","article-title":"RNA-based recognition and targeting: sowing the seeds of specificity","volume":"18","author":"Gorski","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat Rev Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e09-10-0885","article-title":"HSP90 protein stabilizes unloaded argonaute complexes and microscopic P-bodies in human cells","volume":"21","author":"Johnston","year":"2010","journal-title":"Mol Biol Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/cells13161343","article-title":"MiRNAs as regulators of immune cells in the tumor microenvironment of ovarian cancer","volume":"13","author":"Wilczy\u0144ski","year":"2024","journal-title":"Cells"},{"key":"B38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-024-02084-x","article-title":"The role of microRNAs in the gastric cancer tumor microenvironment","volume":"23","author":"Yu","year":"2024","journal-title":"Mol Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112779","article-title":"The role of miR-765 in human cancers","volume":"139","author":"Mohamed","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2118752119","article-title":"A large fraction of trisomy 12, 17p(-), and 11q(-) CLL cases carry unidentified microdeletions of miR-15a\/16-1","volume":"119","author":"Pepe","year":"2022","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16030402","article-title":"Combined Delivery of miR-15\/16 through Humanized Ferritin Nanocages for the Treatment of Chronic Lymphocytic Leukemia","volume":"16","author":"Liberati","year":"2024","journal-title":"Pharmaceutics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2341","article-title":"DNA methylation landscapes: provocative insights from epigenomics","volume":"9","author":"Suzuki","year":"2008","journal-title":"Nat Rev Genet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","article-title":"The diverse roles of DNA methylation in mammalian development and disease","volume":"20","author":"Greenberg","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nature12433","article-title":"Charting a dynamic DNA methylation landscape of the human genome","volume":"500","author":"Ziller","year":"2013","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcription","volume":"25","author":"Deaton","year":"2011","journal-title":"Genes Dev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.07.028","article-title":"Gene body methylation can alter gene expression and is a therapeutic target in cancer","volume":"26","author":"Yang","year":"2014","journal-title":"Cancer Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaj2239","article-title":"Impact of cytosine methylation on DNA binding specificities of human transcription factors","volume":"356","author":"Yin","year":"2017","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrg.2017.80","article-title":"The DNA methyltransferase family: a versatile toolkit for epigenetic regulation","volume":"19","author":"Lyko","year":"2018","journal-title":"Nat Rev Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1126\/science.277.5334.1996","article-title":"Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1","volume":"277","author":"Chuang","year":"1997","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90561-p","article-title":"A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei","volume":"71","author":"Leonhardt","year":"1992","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81656-6","article-title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3354","article-title":"DNA methylation: roles in mammalian development","volume":"14","author":"Smith","year":"2013","journal-title":"Nat Rev Genet"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nature02633","article-title":"Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting","volume":"429","author":"Kaneda","year":"2004","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/ng0797-256","article-title":"A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins","volume":"16","author":"Cross","year":"1997","journal-title":"Nat Genet"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.18.11.6538","article-title":"Identification and characterization of a family of mammalian methyl-CpG binding proteins","volume":"18","author":"Hendrich","year":"1998","journal-title":"Mol Cell Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-9525(03)00080-5","article-title":"The methyl-CpG binding domain and the evolving role of DNA methylation in animals","volume":"19","author":"Hendrich","year":"2003","journal-title":"Trends Genet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90610-o","article-title":"Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA","volume":"69","author":"Lewis","year":"1992","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20222105","article-title":"A novel molecular class that recruits HDAC\/MECP2 complexes to PU.1 motifs reduces neuroinflammation","volume":"220","author":"Ralvenius","year":"2023","journal-title":"J Exp Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2013.12.019","article-title":"Reversing DNA methylation: mechanisms, genomics, and biological functions","volume":"156","author":"Wu","year":"2014","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genet-110711-155451","article-title":"5-Methylcytosine DNA demethylation: more than losing a methyl group","volume":"46","author":"Franchini","year":"2012","journal-title":"Annu Rev Genet"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.08.032","article-title":"TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation","volume":"79","author":"Kaas","year":"2013","journal-title":"Neuron"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3589","article-title":"TETonic shift: biological roles of TET proteins in DNA demethylation and transcription","volume":"14","author":"Pastor","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.06.009","article-title":"The colorful history of active DNA demethylation","volume":"133","author":"Ooi","year":"2008","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2017.33","article-title":"TET-mediated active DNA demethylation: mechanism, function and beyond","volume":"18","author":"Wu","year":"2017","journal-title":"Nat Rev Genet"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku552","article-title":"TET-mediated oxidation of methylcytosine causes TDG or NEIL glycosylase dependent gene reactivation","volume":"42","author":"M\u00fcller","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2217\/epi.12.36","article-title":"DNA demethylation by TDG","volume":"4","author":"Dalton","year":"2012","journal-title":"Epigenomics"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1126\/science.1210944","article-title":"Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA","volume":"333","author":"He","year":"2011","journal-title":"Science"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.146","article-title":"Epigenetic control of CD8(+) T cell differentiation","volume":"18","author":"Henning","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/11.19.6883","article-title":"The 5-methylcytosine content of DNA from human tumors","volume":"11","author":"Gama-Sosa","year":"1983","journal-title":"Nucleic Acids Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/ng.865","article-title":"Increased methylation variation in epigenetic domains across cancer types","volume":"43","author":"Hansen","year":"2011","journal-title":"Nat Genet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"8462","DOI":"10.1158\/0008-5472.Can-06-0293","article-title":"Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers","volume":"66","author":"Rodriguez","year":"2006","journal-title":"Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126516","article-title":"Hypomethylation of CLDN4 gene promoter is associated with Malignant phenotype in urinary bladder cancer","volume":"23","author":"Maesaka","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168761","article-title":"Hypomethylated RRBP1 potentiates tumor Malignancy and chemoresistance in upper tract urothelial carcinoma","volume":"22","author":"Luo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s43556-024-00198-8","article-title":"SOX7 inhibits the Malignant progression of bladder cancer via the DNMT3B\/CYGB axis","volume":"5","author":"Zhang","year":"2024","journal-title":"Mol Biomed"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl128","article-title":"Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer","volume":"15","author":"Xinarianos","year":"2006","journal-title":"Hum Mol Genet"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3181\/0903-rm-98","article-title":"Cell cycle arrest induced by hydrogen peroxide is associated with modulation of oxidative stress related genes in breast cancer cells","volume":"234","author":"Chua","year":"2009","journal-title":"Exp Biol Med (Maywood)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1371","article-title":"Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer","volume":"40","author":"Wojnarowicz","year":"2012","journal-title":"Int J Oncol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/nri3920","article-title":"Regulation of macrophage development and function in peripheral tissues","volume":"15","author":"Lavin","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq5226","article-title":"NF-\u03baB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment","volume":"10","author":"de-la-Calle-Fabregat","year":"2024","journal-title":"Sci Adv"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-17-1589","article-title":"PHGDH as a key enzyme for serine biosynthesis in HIF2\u03b1-targeting therapy for renal cell carcinoma","volume":"77","author":"Yoshino","year":"2017","journal-title":"Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12697","article-title":"Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine\/cisplatin and the contribution of promoter DNA hypomethylation","volume":"14","author":"Yoshino","year":"2020","journal-title":"Mol Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.04.009","article-title":"Understanding the complexity of p53 in a new era of tumor suppression","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2019.1638693","article-title":"TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC)","volume":"18","author":"Bunch","year":"2019","journal-title":"Cell Cycle"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.23736\/s2724-6051.24.05876-2","article-title":"Assessing the influence of smoking on inflammatory markers in bacillus Calmette Gu\u00e9rin response among bladder cancer patients: a novel machine-learning approach","volume":"3","author":"Ferro","year":"2024","journal-title":"Minerva Urol Nephrol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081839","article-title":"Discovery of molecular DNA methylation-based biomarkers through genome-wide analysis of response patterns to BCG for bladder cancer","volume":"9","author":"Ilijazi","year":"2020","journal-title":"Cells"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.91874","article-title":"FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer","volume":"21","author":"Huang","year":"2024","journal-title":"Int J Med Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113102","article-title":"The suppressive role of phytochemical-induced glutathione S-transferase Mu 2 in human urothelial carcinoma cells","volume":"151","author":"Shen","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063056","article-title":"Anti-cancer effects and tumor marker role of glutathione S-transferase mu 5 in human bladder cancer","volume":"22","author":"Jou","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aba0443","article-title":"GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma","volume":"13","author":"Hayashi","year":"2020","journal-title":"Sci Signal"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-1063-4","article-title":"Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer","volume":"39","author":"Osei-Amponsa","year":"2020","journal-title":"Oncogene"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2024.104908","article-title":"Aberrant cell adhesiveness due to DNA hypermethylation of KLF11 in papillary urothelial carcinomas","volume":"137","author":"Tsumura","year":"2024","journal-title":"Exp Mol Pathol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1177\/03946320241240706","article-title":"Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications","volume":"38","author":"Lin","year":"2024","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113232","article-title":"The epigenetic-modified downregulation of LOXL1 protein mediates EMT in bladder epithelial cells exposed to benzo[a]pyrene and its metabolite BPDE","volume":"142","author":"Zou","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/s12951-024-02829-2","article-title":"Apoptotic vesicles rescue impaired mesenchymal stem cells and their therapeutic capacity for osteoporosis by restoring miR-145a-5p deficiency","volume":"22","author":"Zhang","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111613","article-title":"CircRAPGEF5 sponges miR-582-3p and targets KIF3A to regulate bladder cancer cell proliferation, migration and invasion","volume":"131","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.7150\/thno.97755","article-title":"Targeted delivery of anti-miRNA21 sensitizes PD-L1(high) tumor to immunotherapy by promoting immunogenic cell death","volume":"14","author":"Kim","year":"2024","journal-title":"Theranostics"},{"key":"B99","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41419-018-0986-y","article-title":"MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting \u03b2-catenin and CDK2 and activating p21","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27288","article-title":"MicroRNA-133b suppresses bladder cancer Malignancy by targeting TAGLN2-mediated cell cycle","volume":"234","author":"Zhao","year":"2019","journal-title":"J Cell Physiol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1038\/s41467-023-40343-5","article-title":"Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"key":"B102","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41419-024-07000-1","article-title":"TAGLN2 induces resistance signature ISGs by activating AKT-YBX1 signal with dual pathways and mediates the IFN-related DNA damage resistance in gastric cancer","volume":"15","author":"Zhuo","year":"2024","journal-title":"Cell Death Dis"},{"key":"B103","article-title":"MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC","volume":"8","author":"Huang","year":"2016","journal-title":"Am J Transl Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.23","article-title":"The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer","volume":"104","author":"Yoshino","year":"2011","journal-title":"Br J Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605570","article-title":"miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer","volume":"102","author":"Chiyomaru","year":"2010","journal-title":"Br J Cancer"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01332-3","article-title":"An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications","volume":"31","author":"De Florian Fania","year":"2024","journal-title":"Cell Death Differ"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4940","article-title":"miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion","volume":"36","author":"Huang","year":"2016","journal-title":"Oncol Rep"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0155-5","article-title":"Estrogen receptor \u03b2 promotes bladder cancer growth and invasion via alteration of miR-92a\/DAB2IP signals","volume":"50","author":"Ou","year":"2018","journal-title":"Exp Mol Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1377989","article-title":"MiR-20a-5p negatively regulates NR4A3 to promote metastasis in bladder cancer","volume":"2021","author":"Yang","year":"2021","journal-title":"J Oncol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2018.08.001","article-title":"MicroRNA-93 promotes bladder cancer proliferation and invasion by targeting PEDF","volume":"37","author":"Jiang","year":"2019","journal-title":"Urol Oncol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2020.201030","article-title":"MicroRNA-20a targeting LASS2 promotes the proliferation, invasiveness and migration of bladder cancer","volume":"67","author":"Xiao","year":"2021","journal-title":"Clin Lab"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-009-9194-7","article-title":"Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer","volume":"28","author":"McConkey","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1158\/1078-0432.Ccr-13-2805","article-title":"Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine\/glutamate exchanger SLC7A11","volume":"20","author":"Drayton","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2455","article-title":"Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway","volume":"10","author":"Bu","year":"2014","journal-title":"Mol Med Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-234","article-title":"miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway","volume":"13","author":"Deng","year":"2014","journal-title":"Mol Cancer"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.11.002","article-title":"MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene","volume":"357","author":"Lv","year":"2015","journal-title":"Cancer Lett"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2014.12.014","article-title":"The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer","volume":"1852","author":"Deng","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3555","article-title":"The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30817","article-title":"Autophagy blockade potentiates cancer-associated immunosuppression through programmed death ligand-1 upregulation in bladder cancer","volume":"237","author":"Tsai","year":"2022","journal-title":"J Cell Physiol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12885-023-10828-z","article-title":"Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer","volume":"23","author":"Hui","year":"2023","journal-title":"BMC Cancer"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2009.56","article-title":"The miR-34 family in cancer and apoptosis","volume":"17","author":"Hermeking","year":"2010","journal-title":"Cell Death Differ"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.16.6533","article-title":"Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer","volume":"7","author":"Lodygin","year":"2008","journal-title":"Cell Cycle"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-8","article-title":"Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy","volume":"13","author":"Li","year":"2014","journal-title":"Mol Cancer"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.Capr-11-0267","article-title":"Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer","volume":"4","author":"Saini","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"B125","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12943-017-0664-1","article-title":"MicroRNA-608 inhibits proliferation of bladder cancer via AKT\/FOXO3a signaling pathway","volume":"16","author":"Liang","year":"2017","journal-title":"Mol Cancer"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25326","article-title":"Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer","volume":"9","author":"Shindo","year":"2018","journal-title":"Oncotarget"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.367","article-title":"The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2\/PLAU\/HIC2 expression","volume":"5","author":"Lv","year":"2014","journal-title":"Cell Death Dis"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.12.098","article-title":"Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells","volume":"379","author":"Saito","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25461","article-title":"Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer","volume":"128","author":"Wiklund","year":"2011","journal-title":"Int J Cancer"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3892\/or.2011.1253","article-title":"Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines","volume":"25","author":"Yoshitomi","year":"2011","journal-title":"Oncol Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.11.030","article-title":"Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer","volume":"63","author":"Shimizu","year":"2013","journal-title":"Eur Urol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2018.1557490","article-title":"MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1\/MMP9 pathway","volume":"17","author":"Yan","year":"2018","journal-title":"Cell Cycle"},{"key":"B133","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13046-019-1286-9","article-title":"Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness","volume":"38","author":"Richter","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijrobp.2018.12.028","article-title":"MicroRNA biomarkers for patients with muscle-invasive bladder cancer undergoing selective bladder-sparing trimodality treatment","volume":"104","author":"Meng","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2022.10.001","article-title":"Epigenetic regulation of MIR145 core promoter controls miR-143\/145 cluster in bladder cancer progression and treatment outcome","volume":"30","author":"Pilala","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-10-2017","article-title":"Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer","volume":"17","author":"Dudziec","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B137","doi-asserted-by":"publisher","first-page":"ra80","DOI":"10.1126\/scisignal.2001462","article-title":"DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination","volume":"3","author":"Du","year":"2010","journal-title":"Sci Signal"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.10.002","article-title":"Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis","volume":"86","author":"Bronner","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13502","article-title":"MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1","volume":"282","author":"Wang","year":"2015","journal-title":"FEBS J"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-15-0603","article-title":"ATDC\/TRIM29 Drives Invasive Bladder Cancer Formation through miRNA-Mediated and Epigenetic Mechanisms","volume":"75","author":"Palmbos","year":"2015","journal-title":"Cancer Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118311","article-title":"Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer","volume":"261","author":"Liu","year":"2020","journal-title":"Life Sci"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103820","article-title":"DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer","volume":"12","author":"Xu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B143","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12885-024-12490-5","article-title":"Isorhapontigenin inhibition of basal muscle-invasive bladder cancer attributed to its downregulation of SNHG1 and DNMT3b","volume":"24","author":"Meng","year":"2024","journal-title":"BMC Cancer"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1186\/s12885-020-07523-8","article-title":"microRNA-451a promoter methylation regulated by DNMT3B expedites bladder cancer development via the EPHA2\/PI3K\/AKT axis","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cancer"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.373","article-title":"miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3\/AKT2\/c-myc and DNMT1 in bladder cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Cell Death Dis"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32036","article-title":"miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer","volume":"144","author":"Ge","year":"2019","journal-title":"Int J Cancer"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00362","article-title":"Urinary markers in bladder cancer: an update","volume":"8","author":"Santoni","year":"2018","journal-title":"Front Oncol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.2015.1019477","article-title":"Epigenetic biomarkers in the blood of patients with urological Malignancies","volume":"15","author":"Ellinger","year":"2015","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1518144\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:38:49Z","timestamp":1738741129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1518144\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":148,"alternative-id":["10.3389\/fimmu.2025.1518144"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1518144","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"article-number":"1518144"}}